New York, NY, United States of America

Ophthotech Corporation


USPTO Granted Patents = 4

% Expired Patents = 100.0


Trademarks = 1

Forward Citations = 69

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Perry Calias (4 out of 7 patents)

silverMedal David Shima (4 out of 4 patents)

bronzeMedal Anthony P Adamis (4 out of 4 patents)

4.  David Shima (0 patent)


4 patents:

Company Overview
Ophthotech Corporation is a biopharmaceutical company focused on the development of novel treatment options for patients with back-of-the-eye diseases. The company's pipeline includes potential therapies for age-related macular degeneration and other retinal disorders. Ophthotech is committed to advancing innovative solutions that improve the lives of patients with vision-threatening conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1,394 in New York, NY

#3,682 in New York

#60,671 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 69

3 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ophthotech Corporation. Retrieved from https://idiyas.com/company/ophthotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…